Replies to post #6323 on Navidea Biopharmaceuticals Inc (NAVBQ)

[casperboo]

Yes. I have already reviewed it and it looks as if it is nothing substantial. Just far too much compensation for Pykett and Cornelia B. Reininger who do far too little for shareholder value.

Same old, same old.